MannKind to Present at Upcoming Conferences and Annual Stockholders Meeting
VALENCIA, Calif., Jun 02, 2010 (BUSINESS WIRE) --MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at upcoming conferences and its annual stockholders meeting.
- Jefferies 2010 Global Life Sciences Conference on Wednesday, June 9, 2010 at 11:00 AM (EDT) in New York
- 9th Annual Needham Healthcare Conferenceon Wednesday, June 9, 2010 at 8:40 AM (EDT) in New York
- Annual Stockholders Meeting on Thursday, June 10, 2010 at 10:00 AM (EDT) in Danbury
- 2010 Wells Fargo Healthcare Conference on Thursday, June 24, 2010 at 8:00 AM (EDT) in Boston
Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com. Replays of the presentations will be available for 14 days.
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its diabetes pipeline includes AFREZZA and MKC253. MKC253 is currently in phase 1 clinical trials. In March 2009, MannKind submitted an NDA to the FDA requesting approval of AFREZZA for the treatment of adults with Type 1 or Type 2 diabetes for the control of hyperglycemia. In March 2010, MannKind received a Complete Response from the FDA regarding this NDA seeking additional information about AFREZZA. Currently, AFREZZA remains under regulatory review. Other products in its pipeline include the cancer immunotherapy products MKC1106-PP and MKC1106-MT, which are currently in phase 1 clinical trials. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.
SOURCE: MannKind Corporation
MannKind Corporation
Matthew J. Pfeffer
Corporate Vice President and
Chief Financial Officer
661-775-5300
mpfeffer@mannkindcorp.com